These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. Renal amino acid transport systems and essential hypertension. Pinto V; Pinho MJ; Soares-da-Silva P FASEB J; 2013 Aug; 27(8):2927-38. PubMed ID: 23616567 [TBL] [Abstract][Full Text] [Related]
47. [Mechanisms responsible for the renoprotective effects of renin-angiotensin inhibitors]. Nishiyama A Yakugaku Zasshi; 2012; 132(4):455-9. PubMed ID: 22465922 [TBL] [Abstract][Full Text] [Related]
48. A novel interaction between sympathetic overactivity and aberrant regulation of renin by miR-181a in BPH/2J genetically hypertensive mice. Jackson KL; Marques FZ; Watson AM; Palma-Rigo K; Nguyen-Huu TP; Morris BJ; Charchar FJ; Davern PJ; Head GA Hypertension; 2013 Oct; 62(4):775-81. PubMed ID: 23897069 [TBL] [Abstract][Full Text] [Related]
49. RAS blockade decreases blood pressure and proteinuria in transgenic mice overexpressing rat angiotensinogen gene in the kidney. Sachetelli S; Liu Q; Zhang SL; Liu F; Hsieh TJ; Brezniceanu ML; Guo DF; Filep JG; Ingelfinger JR; Sigmund CD; Hamet P; Chan JS Kidney Int; 2006 Mar; 69(6):1016-23. PubMed ID: 16528251 [TBL] [Abstract][Full Text] [Related]
50. Evidence for a critical role of the sympathetic nervous system in hypertension. Grassi G; Ram VS J Am Soc Hypertens; 2016 May; 10(5):457-66. PubMed ID: 27052349 [TBL] [Abstract][Full Text] [Related]
52. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease. Loghman-Adham M; Soto CE; Inagami T; Cassis L Am J Physiol Renal Physiol; 2004 Oct; 287(4):F775-88. PubMed ID: 15187005 [TBL] [Abstract][Full Text] [Related]
53. Renal transporter activation during angiotensin-II hypertension is blunted in interferon-γ-/- and interleukin-17A-/- mice. Kamat NV; Thabet SR; Xiao L; Saleh MA; Kirabo A; Madhur MS; Delpire E; Harrison DG; McDonough AA Hypertension; 2015 Mar; 65(3):569-76. PubMed ID: 25601932 [TBL] [Abstract][Full Text] [Related]
54. Role of dopamine receptors in the kidney in the regulation of blood pressure. Jose PA; Eisner GM; Felder RA Curr Opin Nephrol Hypertens; 2002 Jan; 11(1):87-92. PubMed ID: 11753092 [TBL] [Abstract][Full Text] [Related]
56. The renal nerve is required for regulation of proximal tubule transport by intraluminally produced ANG II. Quan A; Baum M Am J Physiol Renal Physiol; 2001 Mar; 280(3):F524-9. PubMed ID: 11181415 [TBL] [Abstract][Full Text] [Related]
57. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Kobori H; Nangaku M; Navar LG; Nishiyama A Pharmacol Rev; 2007 Sep; 59(3):251-87. PubMed ID: 17878513 [TBL] [Abstract][Full Text] [Related]
58. Upregulation of autocrine-paracrine renin-angiotensin systems in chronic renovascular hypertension. Sadjadi J; Puttaparthi K; Welborn MB; Rogers TE; Moe O; Clagett GP; Turnage RH; Levi M; Modrall JG J Vasc Surg; 2002 Aug; 36(2):386-92. PubMed ID: 12170196 [TBL] [Abstract][Full Text] [Related]
59. Roles of central renin-angiotensin system and afferent renal nerve in the control of systemic hemodynamics in rats. Fujisawa Y; Nagai Y; Lei B; Nakano D; Fukui T; Hitomi H; Mori H; Masaki T; Nishiyama A Hypertens Res; 2011 Nov; 34(11):1228-32. PubMed ID: 21796126 [TBL] [Abstract][Full Text] [Related]